Related Experiment Video
Updated: Jun 1, 2026
08:17
Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis
Published on: February 23, 2024
[Biomarkers in neuroimmunology]
1Service de neurologie, Departement des neurosciences cliniques, HUG, 1211 Geneve 14. patrice.lalive@hcuge.ch
Revue Medicale Suisse
|May 24, 2011
Summary
Biomarkers, particularly autoantibodies, are crucial for diagnosing neurological autoimmune diseases. Detecting these biomarkers aids clinicians in diagnosis and treatment decisions, offering an alternative to invasive nervous biopsies.
Area of Science:
- Neurology
- Immunology
- Clinical Diagnostics
Context:
- Neurological autoimmune diseases present diagnostic challenges.
- Nervous biopsy, while a gold standard, has limitations including risks and low yield.
- Biomarkers, especially autoantibodies, play a key role in disease pathogenesis and diagnosis.
Purpose:
- To review currently available biomarkers for investigating immune-mediated neurological conditions.
- To highlight the clinical utility of biomarkers in diagnosing autoimmune neurological disorders.
- To provide an overview of diagnostic tools for daily clinical practice.
Summary:
- Biomarkers, predominantly autoantibodies, are vital for diagnosing neurological autoimmune diseases.
- Their detection aids in establishing a definitive diagnosis and guiding therapeutic strategies.
- This review focuses on biomarkers accessible for routine clinical investigation of these conditions.
Impact:
- Improved diagnostic accuracy for neurological autoimmune diseases.
- Facilitation of timely and appropriate treatment decisions.
- Reduced reliance on invasive procedures like nervous biopsies.
